Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 132Myelodysplastic Syndromes 57Leukemia 32Leukemia, Myelomonocytic, Chronic 23Recurrence 18Lymphoma, Large B-Cell, Diffuse 10Myeloproliferative Disorders 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Congenital Abnormalities 7Primary Myelofibrosis 6Melanoma 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Blast Crisis 5Thrombocythemia, Essential 4Polycythemia Vera 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma 4Leukemia, Monocytic, Acute 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Neoplasm Metastasis 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2

Interventions

Cyclophosphamide 20Etoposide 19Temozolomide 16Carboplatin 16Filgrastim 15Vincristine 11Cisplatin 11Radiotherapy 10Thiotepa 9Melphalan 8Granulocyte Colony-Stimulating Factor 8etoposide phosphate 7Lomustine 7Peripheral Blood Stem Cell Transplantation 6Radiation 5Methotrexate 5Magnetic Resonance Spectroscopy 5Topotecan 4Mesna 4Gemcitabine 4Busulfan 4sargramostim 3gallium Ga 68 dotatate 3Thalidomide 3Stem Cell Transplantation 3Irinotecan 3Ifosfamide 3Donepezil 3Celecoxib 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Medulloblastoma × Decitabine × Clear all
NCT02332889 2018-05-04

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

University of Louisville

Phase 1/2 Terminated
1 enrolled 6 charts
CNS

Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡